Published in Am J Kidney Dis on April 01, 2009
Association of metabolic syndrome with kidney function and histology in living kidney donors. Am J Transplant (2013) 1.63
Metabolic syndrome, ESRD, and death in CKD. Clin J Am Soc Nephrol (2013) 1.63
Chronic kidney disease and end-stage renal disease in the elderly population: current prevalence, future projections, and clinical significance. Adv Chronic Kidney Dis (2010) 1.44
Kidney aging--inevitable or preventable? Nat Rev Nephrol (2011) 0.99
Impact of treating the metabolic syndrome on chronic kidney disease. Nat Rev Nephrol (2009) 0.96
Metabolic syndrome and chronic kidney disease: Current status and future directions. World J Nephrol (2014) 0.87
Relationship between chronic kidney disease and metabolic syndrome: current perspectives. Diabetes Metab Syndr Obes (2014) 0.85
The association of chronic kidney disease and metabolic syndrome with incident cardiovascular events: multiethnic study of atherosclerosis. Cardiol Res Pract (2011) 0.84
Obesity-related cardiorenal disease: the benefits of bariatric surgery. Nat Rev Nephrol (2013) 0.83
Kidney damage in metabolic syndrome: nip it in the bud. Am J Kidney Dis (2009) 0.83
Acute kidney injury in a patient with metabolic syndrome. Bioimpacts (2015) 0.79
Association of relatives of hemodialysis patients with metabolic syndrome, albuminuria and Framingham Risk Score. PLoS One (2014) 0.77
The evaluation and comparison of kidney length obtained from axial cuts in spiral CT scan with its true length. Adv Biomed Res (2015) 0.75
The Envy of Scholars: Applying the Lessons of the Framingham Heart Study to the Prevention of Chronic Kidney Disease. Rambam Maimonides Med J (2015) 0.75
World Congress on the Insulin Resistance Syndrome, 2009: the kidney, the liver, and insulin resistance. Diabetes Care (2010) 0.75
The metabolic syndrome and chronic kidney disease. Transl Res (2016) 0.75
Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation (2005) 43.74
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med (2008) 38.76
Banting lecture 1988. Role of insulin resistance in human disease. Diabetes (1988) 33.22
The metabolic syndrome--a new worldwide definition. Lancet (2005) 23.51
Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med (2008) 18.27
MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet (2003) 13.69
The Banff 97 working classification of renal allograft pathology. Kidney Int (1999) 9.02
Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care (2005) 7.05
Increasing prevalence of the metabolic syndrome among u.s. Adults. Diabetes Care (2004) 6.68
The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med (2005) 6.23
The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med (2004) 5.45
Hyperuricemia induces endothelial dysfunction. Kidney Int (2005) 5.36
Obesity-related glomerulopathy: an emerging epidemic. Kidney Int (2001) 3.98
Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol (2005) 3.96
The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am (2004) 3.20
Renal injury in the extremely obese patients with normal renal function. Kidney Int (2008) 2.83
Mediators of diabetic renal disease: the case for tgf-Beta as the major mediator. J Am Soc Nephrol (2004) 2.44
Hypothesis: fructose-induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome. Nat Clin Pract Nephrol (2005) 2.24
Fructose-induced metabolic syndrome is associated with glomerular hypertension and renal microvascular damage in rats. Am J Physiol Renal Physiol (2006) 1.94
Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic american indians: the Strong Heart Study. Diabetes Care (2003) 1.72
Effect of pravastatin on loss of renal function in people with moderate chronic renal insufficiency and cardiovascular disease. J Am Soc Nephrol (2003) 1.70
Mechanisms of disease: the hypoxic tubular hypothesis of diabetic nephropathy. Nat Clin Pract Nephrol (2008) 1.52
Midkine is involved in neutrophil infiltration into the tubulointerstitium in ischemic renal injury. J Immunol (2001) 1.40
Nephron mass as a risk factor for progression of renal disease. Kidney Int Suppl (1997) 1.39
Metabolic syndrome and risk of developing chronic kidney disease in Japanese adults. Hypertens Res (2007) 1.25
Glomerular volume and renal histology in obese and non-obese living kidney donors. Kidney Int (2006) 1.23
Metabolic syndrome and chronic kidney disease in Okinawa, Japan. Kidney Int (2006) 1.22
Tubulointerstitial disease: role of ischemia and microvascular disease. Curr Opin Nephrol Hypertens (2003) 1.15
Nodular glomerulosclerosis in the nondiabetic smoker. J Am Soc Nephrol (2007) 1.15
Early mechanisms of renal injury in hypercholesterolemic or hypertriglyceridemic rats. J Am Soc Nephrol (2000) 1.12
Evaluation of the nonneoplastic pathology in tumor nephrectomy specimens: predicting the risk of progressive renal failure. Am J Surg Pathol (2006) 1.10
Oxidant stress in hyperlipidemia-induced renal damage. Am J Physiol Renal Physiol (2000) 1.08
Cardiovascular morbidity and mortality of the metabolic syndrome. Med Clin North Am (2007) 1.07
Midkine is involved in tubulointerstitial inflammation associated with diabetic nephropathy. Lab Invest (2007) 1.05
Lipotoxic and inflammatory phenotypes in rats with uncontrolled metabolic syndrome and nephropathy. Am J Physiol Renal Physiol (2007) 1.00
Blood pressure lowering for the prevention and treatment of diabetic kidney disease. Drugs (2006) 0.97
In addition to insulin resistance and obesity, hyperuricemia is strongly associated with metabolic syndrome using different definitions in Chinese populations: a population-based study (Taichung Community Health Study). Ann Rheum Dis (2008) 0.94
Medial vascular calcification in diabetes mellitus and chronic kidney disease: the role of inflammation. Cardiovasc Hematol Disord Drug Targets (2007) 0.93
Role of angiotensin II in tubulointerstitial injury. Semin Nephrol (2001) 0.93
Interstitial fibrosis in hypercholesterolemic rats: role of oxidation, matrix synthesis, and proteolytic cascades. Kidney Int (1998) 0.91
Obesity and the kidney: why is the kidney at risk? Kidney Int (2007) 0.91
Albuminuria and chronic kidney disease in association with the metabolic syndrome. J Cardiometab Syndr (2007) 0.87
Tubulointerstitial lesions in non-insulin dependent diabetes mellitus. Kidney Int Suppl (1997) 0.84
Metabolic syndrome: an emerging threat to renal function. Clin J Am Soc Nephrol (2007) 0.82
Metabolic syndrome as a risk factor for contrast-induced nephropathy in non-diabetic elderly patients with renal impairment. Kidney Blood Press Res (2006) 0.82
Associations of chronic kidney disease with the metabolic syndrome in non-diabetic elderly. Nephrol Dial Transplant (2006) 0.82
Modulation of glomerular sclerosis and interstitial fibrosis by native and modified lipoproteins. Kidney Int Suppl (1996) 0.82
Angiotensin II and IGF-I may interact to regulate tubulointerstitial cell kinetics and phenotypic changes in hypertensive rats. Hypertens Res (2002) 0.79
A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med (2009) 14.13
Erythropoietic response and outcomes in kidney disease and type 2 diabetes. N Engl J Med (2010) 5.48
Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes. Kidney Int (2008) 3.34
Ferric gluconate reduces epoetin requirements in hemodialysis patients with elevated ferritin. J Am Soc Nephrol (2008) 2.72
Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study. J Am Soc Nephrol (2007) 2.62
Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial. Am J Kidney Dis (2008) 2.31
A comparison of prediction equations for estimating glomerular filtration rate in adults without kidney disease. J Am Soc Nephrol (2003) 2.23
Stroke in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia treated with Darbepoetin Alfa: the trial to reduce cardiovascular events with Aranesp therapy (TREAT) experience. Circulation (2011) 1.87
Hypertension in the developing world: challenges and opportunities. Am J Kidney Dis (2009) 1.79
A secondary analysis of the CHOIR trial shows that comorbid conditions differentially affect outcomes during anemia treatment. Kidney Int (2009) 1.72
Pure red cell aplasia due to follow-on epoetin. Kidney Int (2008) 1.69
Fournier gangrene: role of imaging. Radiographics (2008) 1.68
Epidemiology and risk factors of chronic kidney disease in India - results from the SEEK (Screening and Early Evaluation of Kidney Disease) study. BMC Nephrol (2013) 1.67
Anemia management and association of race with mortality and hospitalization in a large not-for-profit dialysis organization. Am J Kidney Dis (2009) 1.66
A preeclampsia-like syndrome characterized by reversible hypertension and proteinuria induced by the multitargeted kinase inhibitors sunitinib and sorafenib. J Natl Cancer Inst (2008) 1.63
Pharmacological GLI2 inhibition prevents myofibroblast cell-cycle progression and reduces kidney fibrosis. J Clin Invest (2015) 1.59
Medullary amyloidosis associated with apolipoprotein A-IV deposition. Kidney Int (2011) 1.56
Contaminated cocaine and antineutrophil cytoplasmic antibody-associated disease. Clin J Am Soc Nephrol (2011) 1.52
Diabesity: an overview of a rising epidemic. Nephrol Dial Transplant (2010) 1.50
Granulomatous interstitial nephritis: a clinicopathologic study of 46 cases from a single institution. Int J Surg Pathol (2006) 1.45
Ferric gluconate treatment provides cost savings in patients with high ferritin and low transferrin saturation. Kidney Int (2008) 1.43
Alcohol and sexual risk behavior among migrant female sex workers and male workers in districts with high in-migration from four high HIV prevalence states in India. AIDS Behav (2010) 1.43
Acute coronary syndrome in ESRD patients. Kidney Int (2008) 1.43
Hemoglobin stability in patients with anemia, CKD, and type 2 diabetes: an analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) placebo arm. Am J Kidney Dis (2012) 1.38
Trivalent vaccine against botulinum toxin serotypes A, B, and E that can be administered by the mucosal route. Infect Immun (2007) 1.37
Association of anemia and erythropoiesis stimulating agents with inflammatory biomarkers in chronic kidney disease. Kidney Int (2008) 1.34
Frequency of and risk factors for poor cognitive performance in hemodialysis patients. Neurology (2013) 1.34
Prevalence and risk factors of chronic kidney disease in the Thai adult population: Thai SEEK study. Nephrol Dial Transplant (2009) 1.33
Disclosure of the HIV infection status in children. Indian J Pediatr (2009) 1.27
Kidney disease and multiple myeloma. Clin J Am Soc Nephrol (2013) 1.26
Gemcitabine-associated thrombotic microangiopathy. Cancer (2004) 1.26
Rationale--Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): evolving the management of cardiovascular risk in patients with chronic kidney disease. Am Heart J (2005) 1.25
Aerosol chemistry over a high altitude station at northeastern Himalayas, India. PLoS One (2010) 1.19
Does TREAT give the boot to ESAs in the treatment of CKD anemia? J Am Soc Nephrol (2009) 1.17
Evaluation of the nonneoplastic pathology in tumor nephrectomy specimens: predicting the risk of progressive renal failure. Am J Surg Pathol (2006) 1.10
Con: Randomized controlled trials (RCT) have failed in the study of dialysis methods. Nephrol Dial Transplant (2013) 1.09
Lyme disease-associated glomerulonephritis. Nephrol Dial Transplant (2011) 1.08
Collapsing glomerulopathy--a new pattern of renal injury. Semin Diagn Pathol (2002) 1.08
Polymer thin films embedded with metal nanoparticles for electrochemical biosensors applications. Biosens Bioelectron (2012) 1.06
The vascular ectonucleotidase ENTPD1 is a novel renoprotective factor in diabetic nephropathy. Diabetes (2007) 1.02
Prevalence of vitamin D deficiency in Saudi adults. Saudi Med J (2013) 1.02
The role of systemic handling in the pathophysiologic actions of botulinum toxin. J Pharmacol Exp Ther (2008) 1.01
Reduced infectivity of a Leishmania donovani biopterin transporter genetic mutant and its use as an attenuated strain for vaccination. Infect Immun (2002) 1.00
Epidemiology of chronic kidney disease in the Kingdom of Saudi Arabia (SEEK-Saudi investigators) - a pilot study. Saudi J Kidney Dis Transpl (2010) 0.96
Baseline characteristics in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT). Am J Kidney Dis (2009) 0.95
New subcategories of class IV lupus nephritis: are there clinical, histologic, and outcome differences? Am J Kidney Dis (2004) 0.95
Strategies for preservation of ovarian and testicular function after immunosuppression. Am J Kidney Dis (2004) 0.92
Outcomes of renal transplantation for recipients with lupus nephritis: analysis of the Organ Procurement and Transplantation Network database. Transplantation (2006) 0.92
Hidradenitis suppurativa resulting in systemic amyloid A amyloidosis: a case report and review of the literature. Dermatol Online J (2012) 0.91
Skull metastasis in papillary carcinoma of thyroid: A case report. World J Radiol (2012) 0.90
Role of vitamin D in chronic kidney disease. Semin Nephrol (2009) 0.90
Outcome of acute kidney injury in pediatric patients admitted to the intensive care unit. Clin Nephrol (2014) 0.89
A forgotten cause of kidney injury in chronic myelomonocytic leukemia. Am J Kidney Dis (2009) 0.89
Chronic kidney disease in the Arab world: a call for action. Nephron Clin Pract (2012) 0.88
Cardiovascular toxicity of epoetin-alfa in patients with chronic kidney disease. Am J Nephrol (2013) 0.88
Endothelial activation markers in anemic non-dialysis chronic kidney disease patients. Nephron Clin Pract (2008) 0.87
Tc-99m ciprofloxacin scans for detection of tubercular bone infection. Clin Nucl Med (2007) 0.87
Renal crescentic alpha heavy chain deposition disease: a report of 3 cases and review of the literature. Am J Kidney Dis (2011) 0.87
Associations between demographic factors and provider structures on cost and length of stay for hemodialysis patients with vascular access failure. Clin J Am Soc Nephrol (2006) 0.87
The spectrum of kidney involvement in lymphoma: a case report and review of the literature. Am J Kidney Dis (2010) 0.86
ESAs in dialysis patients: are you a hedgehog or a fox? J Am Soc Nephrol (2010) 0.86
Nephrobronchial fistula complicating neglected nephrolithiasis and xanthogranulomatous pyelonephritis. Saudi J Kidney Dis Transpl (2011) 0.85
De novo multifocal renal cell carcinoma in the renal allograft. Kidney Int (2008) 0.84
Transformation of tomato with a bacterial codA gene enhances tolerance to salt and water stresses. J Plant Physiol (2011) 0.83
Burden and predictors of hypertension in India: results of SEEK (Screening and Early Evaluation of Kidney Disease) study. BMC Nephrol (2014) 0.83
The case / progressive hypertension and proteinuria on anti-angiogenic therapy. Kidney Int (2008) 0.83
Posttransplant anemia: the role of sirolimus. Kidney Int (2009) 0.83
Rapidly deteriorating kidney function in a young man previously diagnosed with membranous nephropathy. Nephron Clin Pract (2010) 0.82
Renal impairment in children with posterior urethral valves. Pediatr Nephrol (2012) 0.82
Anemia in chronic kidney disease: new advances. Heart Fail Clin (2010) 0.82
The role of kidney biopsy in the management of lupus nephritis. Curr Opin Nephrol Hypertens (2005) 0.81
Effect of hemoglobin target on progression of kidney disease: a secondary analysis of the CHOIR (Correction of Hemoglobin and Outcomes in Renal Insufficiency) trial. Am J Kidney Dis (2012) 0.81
Immunopathogenesis of lupus and lupus nephritis: recent insights. Curr Opin Nephrol Hypertens (2002) 0.81
Acute phosphate nephropathy. Kidney Int (2008) 0.81
Crystal-storing histiocytosis involving the kidney in a low-grade B-cell lymphoproliferative disorder. Am J Kidney Dis (2002) 0.80
The FDA's perspective on the risk for rapid rise in hemoglobin in treating CKD anemia: Quo Vadis. Clin J Am Soc Nephrol (2010) 0.80
Anemia of chronic kidney disease. Clin J Am Soc Nephrol (2007) 0.79
Glomerular inflammation correlates with endothelial injury and with IL-6 and IL-1β secretion in the peripheral blood. Transplantation (2014) 0.79
Imaging of inflammatory bowel disease: CT and MR. Dig Dis (2004) 0.79
Deciphering the binding modes of hematoporphyrin to bovine serum albumin. Indian J Biochem Biophys (2014) 0.79
Comprehensive laboratory evaluation of a specific lateral flow assay for the presumptive identification of abrin in suspicious white powders and environmental samples. Biosecur Bioterror (2014) 0.79
Kidney disease outcomes quality initiative guidelines for bone and mineral metabolism: emerging questions. Semin Nephrol (2009) 0.79
Impact of the supplementation of kidney mass on blood pressure and progression of kidney disease. Nephrol Dial Transplant (2004) 0.79
Eculizumab for drug-induced de novo posttransplantation thrombotic microangiopathy: A case report. Clin Nephrol (2015) 0.78
Interpreting results of clinical trials: a conceptual framework. Clin J Am Soc Nephrol (2008) 0.78
Anaemia of CKD--the CHOIR study revisited. Nephrol Dial Transplant (2007) 0.78
Brain lesions with elevated lactic acid peaks on magnetic resonance spectroscopy. Curr Probl Diagn Radiol (2004) 0.78
Hypophosphatemia in kidney transplant recipients: report of acute phosphate nephropathy as a complication of therapy. Am J Kidney Dis (2011) 0.78
The optimal hemoglobin in dialysis patients- a critical review. Semin Dial (2008) 0.78
How ions affect the structure of water: a combined Raman spectroscopy and multivariate curve resolution study. J Phys Chem B (2013) 0.78
Complications of chronic kidney disease: anemia, mineral metabolism, and cardiovascular disease. Med Clin North Am (2005) 0.78
An electrochemiluminescence assay for the detection of bio threat agents in selected food matrices and in the screening of Clostridium botulinum outbreak strains associated with type A botulism. J Sci Food Agric (2013) 0.78
A new method for radiolabeling of human immunoglobulin-G and its biological evaluation. J Pharm Bioallied Sci (2012) 0.78
Hemoglobin target in chronic kidney disease: a pediatric perspective. Pediatr Nephrol (2008) 0.77